Form 4: Exact Sciences Executive Brian Baranick Reports Stock Transactions
SEC Form 4 Filing
Brian Baranick, EVP, GM, Precision Oncology at Exact Sciences Corp, reports the vesting and disposal of restricted stock units for tax purposes.
Summary
- Brian Baranick, an executive at Exact Sciences Corp, filed a Form 4 detailing changes in beneficial ownership.
- On February 25, 2025, Mr. Baranick vested 3,954 shares of common stock from restricted stock units.
- He also disposed of 2,008 shares to cover tax withholding obligations at a price of $51.28 per share.
- Following these transactions, Mr. Baranick directly owns 17,833 shares of Exact Sciences common stock and indirectly owns 670 shares through a 401(k) plan.
- He also holds 88,103 vested and unvested options and restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects routine stock transactions related to executive compensation, with no indication of positive or negative sentiment.
Future Outlook
The reporting person will continue to vest in restricted stock units in the future.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 02/24/2025 | Date of restricted stock units acquisition |
| 02/25/2025 | Date of common stock transaction and restricted stock unit vesting |
| 02/26/2025 | Date of signature on the Form 4 filing |
| 02/27/2026 | First vesting date of new restricted stock units |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.